• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Neuland Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3800.0
  • ISIN : INE794A01010
12,071.55 2 (0.02%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    11,734.85

  • Today’s High

    12,797.40

  • Open

    12,037.00

  • Perv Close

    12,069.20

  • 52W Low

    5,540.10

  • 52W High

    18,100.00

Key Indicators

  • P/E(TTM)

    64.72

  • Mar.Cap (₹Cr.)

    15,487.66

  • Div & Yield %

    0.12

  • Book Value(₹)

    1,081.52

  • Debt-Equity Ratio

    0.02

  • AGM Date

    28-Mar-2025

  • EPS

    186.59

  • P/E Ratio

    64.72

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    15,487.66

  • RONW (%)

    26.38

  • ROCE (%)

    33.01

Score Board

  • Equity (₹ in Cr.)

    12.83

  • BV (₹)

    1,081.50

  • Sales( ₹ in Cr.)

    1,558.58

  • NP (in Cr.)

    299.90

  • NP Var(%)

    83.0

  • Div%

    140.0

  • CPS (₹)

    280.30

  • EPS (₹)

    233.70

  • Traded Value (₹ in Lakhs)

    15,494.59

  • 52 Week High

    18,100.00

  • 52 Week Low

    5,540.10

  • Price BSE

    12077.0

  • Price NSE

    12,072.00

  • Market Capital( in Cr.)

    15,494.59

  • P/C Ratio

    43.10

  • P/E Ratio

    51.70

  • Price Vs.BV

    233.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,558.58 1,191.20 951.08 936.91 762.71 666.83
Excise Duty 1,447.48 1,115.62 887.38 881.25 708.98 625.77
Net Sales 1,558.58 1,191.20 951.08 936.91 762.71 666.83
Other Income 12.54 9.75 2.08 16.09 3.89 3.49
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,571.12 1,200.95 953.15 953.01 766.60 670.32
EXPENDITURE :
Raw Materials 1,447.48 1,115.62 887.38 881.25 708.98 625.77
Power & Fuel Cost 1,447.48 1,115.62 887.38 881.25 708.98 625.77
Employee Cost 248.53 194.84 175.76 144.02 118.48 104.47
Other Manufacturing Expenses 10.04 22.77 9.12 11.93 13.21 8.76
Selling & Administrative Expenses 104.29 88.50 70.50 79.80 51.76 52.57
Miscellaneous Expenses 10.04 22.77 9.12 11.93 13.21 8.76
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,170.36 985.73 871.41 848.05 714.10 650.49
Operating Profit 156.51 135.56 131.36 116.31 97.60 76.91
Interest 14.00 13.07 13.49 17.90 21.57 15.66
Gross Profit 400.77 215.21 81.74 104.96 52.50 19.84
Depreciation 59.70 52.78 49.04 39.68 31.28 25.86
Profit Before Tax 400.77 215.21 81.74 104.96 52.50 19.84
Tax 99.59 50.39 20.42 12.48 0.00 5.44
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.59 1.70 -2.22 12.18 36.62 -1.75
Reported Net Profit 299.60 163.12 63.53 80.29 15.88 16.14
Extraordinary Items 400.77 215.21 81.74 104.96 52.50 19.84
Adjusted Net Profit 299.60 163.12 63.53 80.29 15.88 16.14
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 17.96 12.83 6.41 6.41 2.57 0.00
P & L Balance carried down 299.60 163.12 63.53 80.29 15.88 16.14
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 140.00 100.00 50.00 50.00 20.00 0.00
Dividend Per Share(Rs) 14.00 10.00 5.00 5.00 2.00 0.00
Earnings Per Share-Unit Curr 233.51 127.14 49.52 62.58 12.38 12.83
Book Value 17.96 12.83 6.41 6.41 2.57 0.00
Book Value(Adj)-Unit Curr 17.96 12.83 6.41 6.41 2.57 0.00

Shareholding Pattern

  • Promoter Group

    32.68%

  • Public Share Holding

    67.32%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 200 200.00 200 200
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 200 0.00 200 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,192,484 32.68 4,192,484 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,192,484 32.68 4,192,484 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 51,304 0.40 51,304 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3,061,125 23.86 3,061,125 198
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 73,246 0.57 73,246 1
Mutual Funds / UTI 806,587 6.29 806,587 16
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 285,544 2.23 285,544 30
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,277,806 33.34 4,277,806 246
2] Non Institution
Bodies Corporate 685,647 5.34 684,847 683
Clearing Members 5,521 0.04 5,521 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 162,411 1.27 149,911 1,094
Foreign Non Institution Other 100 0.00 0 1
Hindu Undivided Families 95,183 0.74 93,783 806
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 952,527 7.42 952,527 11
Individuals holding nominal share capital up to Rs. 1 lakh 2,389,424 18.62 2,340,402 36,444
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 21,958 0.17 21,958 12
Others 46,628 0.36 46,628 1
Sub Total 4,359,399 33.98 4,295,577 39,058
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,829,889 100.00 12,766,067 39,315

Company Background

Neuland Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Neuland Laboratories Ltd
  • BSE Code : 3800.0
  • ISIN : INE794A01010

  • Incorporation Year

    1984

  • Registered Office

    11 Th Floor Phoenix IVY Buildi
    Plot No 573A-III Road No 82, Hyderabad,
    Telangana-500035

  • Telephone

    91-40-30211600

  • FAX

    91-40-30211602

  • Chairman

    D Saharsh Rao

  • Managing Director

  • Company Secretary

    Sarada Bhamidipati

  • Auditor

    MSKA & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Neuland Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Neuland Labs. 12,076.95 1,571.12 1,558.58 51.77 33.13
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92